METiS Therapeutics
- Website
- metistx.com
- Total Funding
- $86.0M
- Last Round
- $86.0M Series ADec 2021
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
METiS Therapeutics is a Biotech company. It has raised $86.0M in total across 1 round, most recently a $86.0M Series A round in Dec 2021. Investors include Frees Fund, PICC Capital Investment and China Life Private Equity.
Funding History
Dec 2021
Investors
Similar Companies
Biotechnology company developing multi-cancer early detection blood tests using high-intensity ge...
Ultima Genomics develops high-throughput DNA sequencing platforms that use open-wafer technology ...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/metis-therapeutics"><img src="https://indexed.vc/api/badge/company/metis-therapeutics" alt="METiS Therapeutics on Indexed.vc" width="260" height="76" /></a>